个性化文献订阅>文章检索
  文章名  
  作者  
  期刊名  
  摘要  
   
   
   
  如果没有找到您所需要的文献,请点击 ——此处申请  
  共14条记录  
  • Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes
    [作者:ROMINE JEFFREY L; ST LAURENT DENIS R; LEET JOHN E; MARTIN SCOTT W; SERRANOWU MICHAEL H; YANG FUKANG; GAO MIN; OBOYLE DONALD R II; LEMM JULIE A; SUN JINHUA; NOWER PETER T; HUANG XIAOHUA STELLA; DESHPANDE MILIND S; MEANWELL NICHOLAS A; SNYDER LAWRENCE B,期刊:ACS Medicinal Chemistry Letters, 页码:224-229 , 文章类型: Article,,卷期:2011年2-3]
  • The iminothiazolidinone BMS-858 (2) was identified as a specific inhibitor of HCV replication in a genotype 1b replicon assay via a high-throughput screening campaign. A more potent analogue, BMS-824 (18), was used in re...
  • Discovery of a Potent and Short-Acting Oral Calcilytic with a Pulsatile Secretion of Parathyroid Hormone
    [作者:SHINAGAWA YUKO; INOUE TERUHIKO; KATSUSHIMA TAKEO; KIGUCHI TOSHIHIRO; IKENOGAMI TAKU; OGAWA NAOKI; FUKUDA KENJI; HIRATA KAZUYUKI; HARADA KAZUHITO; TAKAGI MASAKI; NAKAGAWA TAKASHI; KIMURA SHUICHI; MATSUO YUSHI; MAEKAWA MARIKO; HAYASHI MILDO; SOEJIMA YUKI; TAKAHASHI MITSURU; SHINDO MASANORI; HASHIMOTO HIROMASA,期刊:ACS Medicinal Chemistry Letters, 页码:238-242 , 文章类型: Article,,卷期:2011年2-3]
  • Short-acting oral calcilytics, calcium-sensing receptor (CaSR) antagonists, have been considered as alternatives for parathyroid hormone (PTH), an injectable bone anabolic drug used in the treatment of osteoporosis. Prev...
  • In Vitro and In Vivo Osteogenic Activity of Largazole
    [作者:LEE SUUI; KWAK HAN BOK; PI SUNGHEE; YOU HYUNGKEUN; BYEON SEONG RIM; YING YONGCHENG; LUESCH HENDRIK; HONG JIYONG; KIM SEONG HWAN,期刊:ACS Medicinal Chemistry Letters, 页码:248-251 , 文章类型: Article,,卷期:2011年2-3]
  • Due to their capability of modifying chromatin structure and thereby regulating gene transcription, histone deacetylases (HDACs) have been reported to play important roles in osteogenesis and considered a promising poten...
  • Discovery of MK-1220: A Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure
    [作者:RUDD MICHAEL T; MCCAULEY JOHN A; BUTCHER JOHN W; ROMANO JOSEPH J; MCINTYRE CHARLES J; NGUYEN KEVIN T; GILBERT KEVIN F; BUSH KIMBERLY J; HOLLOWAY M KATHARINE; SWESTOCK JOHN; WAN BANGLIN; CARROLL STEVEN S; DIMUZIO JILLIAN M; GRAHAM DONALD J; LUDMERER STEVEN W; STAHLHUT MARK W; FANDOZZI CHRISTINE M; TRAINOR NICOLE; OLSEN DAVID B; VACCA JOSEPH P; LIVERTON NIGEL J,期刊:ACS Medicinal Chemistry Letters, 页码:207-212 , 文章类型: Article,,卷期:2011年2-3]
  • The discovery of MK-1220 is reported along with the development of a series of HCV NS3/4A protease inhibitors containing a P2 to P4 macrocyclic constraint with improved preclinical pharmacokinetics. Optimization of the P...
  • Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A(2B) Adenosine Receptor Antagonist
    [作者:EASTWOOD PAUL; ESTEVE CRISTINA; GONZALEZ JACOB; FONQUERNA SILVIA; AIGUADE JOSEP; CARRANCO INES; DOMENECH TERESA; APARICI MONICA; MIRALPEIX MONTSERRAT; ALBERTI JOAN; CORDOBA MONICA; FERNANDEZ RAQUEL; PONT MERCE; GODESSART NURIA; PRATS NEUS; ISABEL LOZA MARIA; ISABEL CADAVID MARIA; NUEDA ARSENIO; VIDAL BERNAT,期刊:ACS Medicinal Chemistry Letters, 页码:213-218 , 文章类型: Article,,卷期:2011年2-3]
  • The structure activity relationships for a series of pyrazine-based A(2B) adenosine receptor antagonists are described. From this work, LAS101057 (17), a potent, selective, and orally efficacious A(2B) receptor antagonis...